Rita Dalal
About Rita Dalal
Rita Dalal is the Executive Director at Alkermes in Massachusetts, United States, with extensive experience in clinical development and pharmacovigilance.
Company
Rita Dalal is currently working at Alkermes as the Executive Director. Alkermes, located in Massachusetts, United States, is a prominent biopharmaceutical company known for its dedication to developing therapies for central nervous system diseases and oncology. At Alkermes, Rita is involved in writing statistical analysis plans, creating randomization schedules, conducting interim and final statistical analyses, and collaborating with study sponsors on clinical trial design.
Title
Rita Dalal serves as the Executive Director at Alkermes. Her role encompasses a variety of responsibilities, including statistical analysis, clinical trial design, and collaboration with SAS programmers to ensure accurate data analysis. She also oversees the development and review of Standard Operating Procedures (SOPs) and other critical documents.
Education and Expertise
Rita Dalal has an extensive educational background. She earned her Master's in Public Health (MPH) with a focus on Biostatistics and Epidemiology from UMass Boston, completing her studies in 2001. Prior to that, she obtained her MBBS in Medicine and Surgery from Devi Ahilya University in 1992. Rita also holds a Bachelor of Science degree in Biology/Biological Sciences from Vikram University, achieved in 1986. Her expertise spans biostatistics, epidemiology, clinical research, and drug development.
Background
Rita Dalal has a diverse and extensive background in clinical research, biostatistics, and pharmacovigilance. She began her career at PPD as a Biostatistician in 2004 before moving on to roles at Cordis Corporation, i3 statprobe, ImClone Systems, Eli Lilly and Company, and Merck. She has held various senior positions, such as Senior Biostatistician, Senior Clinical Research Scientist, and Senior Medical Director. Her previous experience includes working as a VP, Consultant in Clinical Development and Pharmacovigilance at Dalal Clinical Research Consulting, LLC and Symphogen A/S.
Achievements
Rita Dalal has led numerous significant projects throughout her career. She was responsible for the validation of datasets, tables, and figures for a multicenter phase II/phase III trial study evaluating combination therapy for hypertension. She developed derived dataset and analysis plan specifications for a pharmacokinetic and pharmacodynamic study of supportive therapy in critically ill patients. Additionally, Rita evaluated the therapeutic response rate of a drug used in cancer treatment, showcasing her expertise in clinical development and drug efficacy analysis.